Cafepharma Today

June 11 2025 - BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
Novo Nordisk, Deep Apple launch drug discovery alliance for weight loss oral therapies
Eli Lilly works out $650M Juvena pact to find muscle-boosting drugs
Nvidia announces massive new initiatives in pharma and clinical research
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

As financial headwinds pick up, pharmas are aiming to squeeze more ROI from their R&D
Pharma Voice
Wednesday, February 5, 2025 - 11:20am
tags:
R&D, drug development
Qlaris sees double as drug reduces eye pressure in pair of phase 2 trials
Fierce Biotech
Wednesday, February 5, 2025 - 11:19am
tags:
Qlaris Bio, clinical trials, ocular hypertension, open angle glaucoma
Liva buys Momenta to bolster digital health platform
Pharmaphorum
Wednesday, February 5, 2025 - 11:18am
tags:
digital health, Medtech, Liva Healthcare, M&A, Momenta
Alys Pharmaceuticals receives regulatory approvals for alopaecia areata drug trial
Clinical Trials Arena
Wednesday, February 5, 2025 - 11:17am
tags:
Alys Pharmaceuticals, FDA, Health Canada, clinical trials, ALY-101, alopecia areata
Lilly’s investigational Alzheimer’s to be investigated in prevention trial
Clinical Trials Arena
Wednesday, February 5, 2025 - 11:14am
tags:
clinical trials, Eli Lilly, remternetug, Alzheimer's disease
Bristol Myers Squibb, Kyowa Kirin layoffs hit 119 in New Jersey amid separate restructuring campaigns
Fierce Pharma
Tuesday, February 4, 2025 - 6:37pm
tags:
Bristol Myers Squibb, layoffs, New Jersey, Kyowa Kirin
China puts PVH Corp, Illumina on its unreliable entity list
Yahoo/Reuters
Tuesday, February 4, 2025 - 6:36pm
tags:
Medtech, China, Illumina
Supernus' 4th try proves the charm with long-awaited FDA approval for Parkinson's infusion pump Onapgo
Fierce Pharma
Tuesday, February 4, 2025 - 6:34pm
tags:
Supernus Pharmaceuticals, Parkinson's Disease, Onapgo, FDA
FDA Approves Susvimo for Diabetic Macular Edema
Managed Healthcare Executive
Tuesday, February 4, 2025 - 6:14pm
tags:
Genentech, Susvimo, diabetic macular edema, FDA
Investors seek answers on Novo Nordisk's next-gen obesity drug CagriSema
Yahoo/Reuters
Tuesday, February 4, 2025 - 6:11pm
tags:
Novo Nordisk, CagriSema
French biotech discontinues all clinical activities, shuts down US site
Fierce Biotech
Tuesday, February 4, 2025 - 6:09pm
tags:
Valerio Therapeutics, clinical trials
RFK Jr. clears key hurdle on path to become HHS secretary
BioPharma Dive
Tuesday, February 4, 2025 - 11:07am
tags:
Robert F Kennedy Jr., Senate, HHS, Donald Trump
Musk's Advertising Lawsuit Names Abbott
Medical Devices and Diagnostics Industry
Tuesday, February 4, 2025 - 10:55am
tags:
Elon Musk, legal, Abbott Labs
Turnstone ends last remaining clinical program due to costs, plots more layoffs
Fierce Biotech
Tuesday, February 4, 2025 - 10:52am
tags:
Turnstone Biologics, layoffs
Pfizer takes $1.2B hit after assessing prospects of Seagen ADCs
Fierce Biotech
Tuesday, February 4, 2025 - 9:55am
tags:
Pfizer, earnings, Seagen, M&A
The End of an Era: Baxter’s CEO Has Retired
Medical Devices and Diagnostics Industry
Tuesday, February 4, 2025 - 9:46am
tags:
Baxter International, Jose Almeida. medtech
Merck’s 2025 revenue outlook falls short as it pauses Gardasil vaccine shipments to China
CNBC
Tuesday, February 4, 2025 - 9:36am
tags:
Merck, earnings, Gardasil, China
Astellas fires CSO and chief manufacturing officer in C-suite shake-up
Fierce Biotech
Tuesday, February 4, 2025 - 9:29am
tags:
Astellas, executives
FDA labels recall of discontinued Olympus endoscope accessory as Class I
Medtech Dive
Tuesday, February 4, 2025 - 9:28am
tags:
Medtech, Olympus, endoscopes, device recalls, FDA
Aplagon secures funding to support Phase IIa trial of APAC therapeutic
Clinical Trials Arena
Tuesday, February 4, 2025 - 9:26am
tags:
Aplagon, APAC, clinical trials, peripheral arterial occlusive disease

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.